Tag: Moderna

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec. 31, 2020-- Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today ...

Total of 160 million doses ordered by the European Commission to date CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec. 18, 2020-- Moderna, Inc. (Nasdaq: ...

Additional funding to support expanded mRNA-1273 clinical development plan including 30,000 participant Phase 3 COVE study conducted in collaboration with ...